Newrhein
7+Portfolio
Private equity‑style venture capital investing in later‑stage, de‑risked life‑science assets with proven clinical safety and efficacy, focusing on cost‑effective, repurposed products that deliver health benefits and economic value.
Where they invest
Geography
Portfolio footprintHover a country to explore
- United States of America
- 71.4%
- Canada
- 14.3%
Darker countries represent a larger share of the portfolio.
What they back
Industries
- Biotechnology
- 42.9%
- Healthcare Technology
- 42.9%
- Medical Devices
- 42.9%
- Digital Health
- 28.6%
- Manufacturing / Industry 4.0
- 14.3%
- Data & Analytics
- 14.3%
% of all portfolio companies. Industry categories can overlap.
Stages
Stage indicator
No stages listed